foxo4 dri senolytic peptide study 2017 cell The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Peptide 10 mg Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link
Pay in 4 interest-free payments of $6.76 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




